ECSP003525A - Antagonistas del receptor de il- 8 iv - Google Patents
Antagonistas del receptor de il- 8 ivInfo
- Publication number
- ECSP003525A ECSP003525A EC2000003525A ECSP003525A ECSP003525A EC SP003525 A ECSP003525 A EC SP003525A EC 2000003525 A EC2000003525 A EC 2000003525A EC SP003525 A ECSP003525 A EC SP003525A EC SP003525 A ECSP003525 A EC SP003525A
- Authority
- EC
- Ecuador
- Prior art keywords
- receiver antagonists
- antagonists
- receiver
- chemokine
- interleukin
- Prior art date
Links
- 108090001007 Interleukin-8 Proteins 0.000 title abstract 3
- 239000005557 antagonist Substances 0.000 title 1
- 102000004890 Interleukin-8 Human genes 0.000 abstract 2
- 235000013877 carbamide Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- -1 phenyl ureas Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Esta invención se refiere a nuevas fenil-ureas útiles en el tratamiento de estados de enfermedades mediados por la quimiocina interleucina-8(IL-8)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13967499P | 1999-06-16 | 1999-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP003525A true ECSP003525A (es) | 2002-01-25 |
Family
ID=22487784
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2000003525A ECSP003525A (es) | 1999-06-16 | 2000-06-12 | Antagonistas del receptor de il- 8 iv |
EC2000003528A ECSP003528A (es) | 1999-06-16 | 2000-08-14 | Antagonistas del receptor de il - 8 vi |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2000003528A ECSP003528A (es) | 1999-06-16 | 2000-08-14 | Antagonistas del receptor de il - 8 vi |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1191934A4 (es) |
JP (1) | JP2003501471A (es) |
KR (1) | KR20020009635A (es) |
CN (1) | CN1494424A (es) |
AR (1) | AR029368A1 (es) |
AU (1) | AU766086B2 (es) |
BR (1) | BR0010985A (es) |
CA (1) | CA2377397A1 (es) |
CZ (1) | CZ20014490A3 (es) |
EC (2) | ECSP003525A (es) |
HK (1) | HK1044716A1 (es) |
HU (1) | HUP0202019A3 (es) |
IL (1) | IL146214A0 (es) |
MX (1) | MXPA01013287A (es) |
NO (1) | NO20016065L (es) |
NZ (1) | NZ515232A (es) |
PE (1) | PE20010319A1 (es) |
PL (1) | PL352218A1 (es) |
TR (1) | TR200103690T2 (es) |
UY (1) | UY26209A1 (es) |
WO (1) | WO2000076516A1 (es) |
ZA (1) | ZA200110203B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6642215B2 (en) * | 2001-05-24 | 2003-11-04 | Leo Pharma A/S | Method of modulating NF-kB activity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0678298B2 (ja) * | 1988-03-30 | 1994-10-05 | ワーナー‐ランバート・コンパニー | N‐〔〔(2,6‐ジ置換)フエニル〕‐n′‐アリールアルキル〕尿素 |
US5780483A (en) * | 1995-02-17 | 1998-07-14 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
AR008290A1 (es) * | 1996-08-15 | 1999-12-29 | Smithkline Beecham Corp | Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios. |
-
2000
- 2000-06-12 EC EC2000003525A patent/ECSP003525A/es unknown
- 2000-06-14 AR ARP000102925A patent/AR029368A1/es not_active Application Discontinuation
- 2000-06-14 UY UY26209A patent/UY26209A1/es not_active Application Discontinuation
- 2000-06-14 PE PE2000000589A patent/PE20010319A1/es not_active Application Discontinuation
- 2000-06-16 IL IL14621400A patent/IL146214A0/xx unknown
- 2000-06-16 NZ NZ515232A patent/NZ515232A/xx unknown
- 2000-06-16 KR KR1020017016140A patent/KR20020009635A/ko not_active Application Discontinuation
- 2000-06-16 BR BR0010985-1A patent/BR0010985A/pt not_active IP Right Cessation
- 2000-06-16 AU AU57482/00A patent/AU766086B2/en not_active Ceased
- 2000-06-16 CN CNA008089205A patent/CN1494424A/zh active Pending
- 2000-06-16 MX MXPA01013287A patent/MXPA01013287A/es unknown
- 2000-06-16 HU HU0202019A patent/HUP0202019A3/hu unknown
- 2000-06-16 WO PCT/US2000/016813 patent/WO2000076516A1/en not_active Application Discontinuation
- 2000-06-16 PL PL00352218A patent/PL352218A1/xx not_active Application Discontinuation
- 2000-06-16 CA CA002377397A patent/CA2377397A1/en not_active Abandoned
- 2000-06-16 TR TR2001/03690T patent/TR200103690T2/xx unknown
- 2000-06-16 EP EP00942933A patent/EP1191934A4/en not_active Withdrawn
- 2000-06-16 CZ CZ20014490A patent/CZ20014490A3/cs unknown
- 2000-06-16 JP JP2001502849A patent/JP2003501471A/ja not_active Withdrawn
- 2000-08-14 EC EC2000003528A patent/ECSP003528A/es unknown
- 2000-12-12 ZA ZA200110203A patent/ZA200110203B/xx unknown
-
2001
- 2001-12-12 NO NO20016065A patent/NO20016065L/no not_active Application Discontinuation
-
2002
- 2002-08-27 HK HK02106332.2A patent/HK1044716A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
NZ515232A (en) | 2004-02-27 |
TR200103690T2 (tr) | 2002-05-21 |
PE20010319A1 (es) | 2001-05-24 |
ECSP003528A (es) | 2002-01-25 |
AU5748200A (en) | 2001-01-02 |
MXPA01013287A (es) | 2002-06-04 |
ZA200110203B (en) | 2002-09-11 |
EP1191934A4 (en) | 2004-02-04 |
CN1494424A (zh) | 2004-05-05 |
PL352218A1 (en) | 2003-08-11 |
KR20020009635A (ko) | 2002-02-01 |
AU766086B2 (en) | 2003-10-09 |
NO20016065D0 (no) | 2001-12-12 |
BR0010985A (pt) | 2002-03-26 |
HUP0202019A3 (en) | 2003-03-28 |
HUP0202019A2 (en) | 2002-10-28 |
UY26209A1 (es) | 2000-12-29 |
EP1191934A1 (en) | 2002-04-03 |
WO2000076516A1 (en) | 2000-12-21 |
IL146214A0 (en) | 2002-07-25 |
CZ20014490A3 (cs) | 2002-07-17 |
HK1044716A1 (zh) | 2002-11-01 |
NO20016065L (no) | 2001-12-12 |
JP2003501471A (ja) | 2003-01-14 |
AR029368A1 (es) | 2003-06-25 |
CA2377397A1 (en) | 2000-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR10391A (es) | Antagonistas del receptor de la il-8. | |
ATE419845T1 (de) | Il-8-rezeptor-antagonisten | |
NO986110L (no) | IL-8 reseptor-antagonister | |
TR200101772T2 (tr) | IL-8 Reseptörü antagonistleri olarak hidroksi difenil üre sülfonamidler | |
CY1106514T1 (el) | Ανταγωνιστες υποδοχεων il-8 | |
TR199901710T2 (xx) | IL-8 resept�r antagonistleri. | |
SMP200600024B (it) | 2,6-Biseteroaril-4-amminopirimidine come antagonisti del recettore dell'adenosina | |
TR199900318T2 (xx) | IL-8 resept�r antagonistleri. | |
UY26601A1 (es) | Antagonistas de los receptores de il-8 | |
PT1129096E (pt) | Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos | |
ATE424194T1 (de) | Adenosin-a2a-rezeptor-antagonisten in kombination mit verbindungen mit neurotrophischer aktivität bei der behandlung von morbus parkinson | |
NZ514696A (en) | IL-8 receptor antagonists | |
AP1548A (en) | Il-8 Receptor Antagonists. | |
ECSP003525A (es) | Antagonistas del receptor de il- 8 iv | |
WO2001068569A3 (en) | Il-8 receptor antagonists | |
BR0010843A (pt) | Antagonistas de receptores de il-8 | |
MY143477A (en) | Il-8 receptor antagonists | |
UY26206A1 (es) | Antagonistas del receptor de il-8. | |
WO2000072800A3 (en) | Il-8 receptor antagonists | |
ECSP003527A (es) | Antagonistas del receptor de il - 8 v | |
AP2002002606A0 (en) | INTERLEUKIN 8 RECEPTOR ANTAGONISTS | |
ECSP003529A (es) | Antagonistas del receptor de il - 8 vii | |
BR0010863A (pt) | Antagonistas de receptores de il-8 | |
WO2001064165A3 (en) | Il-8 receptor antagonists | |
WO2001076530A3 (en) | Il-8 receptor antagonists |